Form EFFECT Theriva Biologics, Inc.
Tweet
Share
E-mailGet inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | December 8, 2022 |
| Accession Number: | 0001104659-22-124554 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
- Northwest Arkansas' First Robotic Total Knee Arthroplasty in an ASC Performed by C. Kris Hanby, M.D., of Ozark Orthopaedics
- Cohen Veterans Network Welcomes First Lady Jill Biden at the Cohen Clinic at VVSD in Oceanside, CA
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
